XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
  UK
  USA
  World
  India
  South Africa
  New Zealand
  Australia
  Canada Healthcare
  China Healthcare
  Africa
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Africa Channel
subscribe to Africa newsletter

Medical News : Healthcare : Africa

   DISCUSS   |   EMAIL   |   PRINT
HIV/AIDS trials under-represented in sub-Saharan research
Oct 6, 2005, 21:48, Reviewed by: Dr.

People in sub-Saharan Africa carry the heaviest burden of HIV and AIDS, yet very few trials have been conducted on the African continent over the past two decades, say researchers in recent BMJ.

 
A study in BMJ confirms previous findings that HIV/AIDS trials are under-represented in sub-Saharan research and suggests that publication of trial results continues to be driven by researchers external to the continent.

The team identified and mapped all randomised controlled trials on HIV and AIDS conducted wholly or partly in Africa and reported before 2004.

After extensive searching, they identified 77 trials published or reported from 1987 to 2003. Most of the trials were funded by government agencies outside Africa, pharmaceutical companies and international non-government or inter-government organisations. Few principal investigators were based in African countries and there was no mention of ethical approval or informed consent in 19 and 17 trials, respectively.

The relatively small number of HIV/AIDS trials conducted in Africa is not commensurate with the burden of disease, say the authors. This may reflect a lack of economic ability, political will, or research capacity.

Geographical mapping as an adjunct to prospective trial registration is a useful tool for researchers and decision makers to track existing and future trials, they conclude.
 

- British Medical Journal, 1 October 2005 (Vol 331, No 7519)
 

Read full text of the source article at Journal's Website

 
Subscribe to Africa Newsletter
E-mail Address:

 

Nandi Siegfried, South African Nuffield Medical Fellow, UK Cochrane Centre, Oxford, UK

Related Africa News

African Union and UN Agencies launch HIV Prevention Acceleration in Africa
53 African countries meet in Brazzaville to discuss scaling up of HIV prevention
Impact on child mortality of removing user fees in Africa
HIV/AIDS trials under-represented in sub-Saharan research
Notable Success in KwaZulu–Natal Malaria Crisis
91 per cent drop in Measles cases in Africa
Discriminatory Attitudes of Health Workers against People Living with HIV
WHO appoints Dr Pascoal Mocumbi as Goodwill Ambassador for maternal mortality reduction in the African Region
Road Map to Intensify Action Against TB in Africa


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us